Annual Retained Earnings
-$165.26 M
-$29.49 M-21.72%
31 December 2023
Summary:
Tempest Therapeutics annual retained earnings is currently -$165.26 million, with the most recent change of -$29.49 million (-21.72%) on 31 December 2023. During the last 3 years, it has fallen by -$93.50 million (-130.30%). TPST annual retained earnings is now -130.30% below its all-time high of -$71.76 million, reached on 31 December 2020.TPST Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$193.29 M
-$10.56 M-5.78%
30 September 2024
Summary:
Tempest Therapeutics quarterly retained earnings is currently -$193.29 million, with the most recent change of -$10.56 million (-5.78%) on 30 September 2024. Over the past year, it has dropped by -$35.52 million (-22.51%). TPST quarterly retained earnings is now -169.36% below its all-time high of -$71.76 million, reached on 31 December 2020.TPST Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -21.7% | -22.5% |
3 y3 years | -130.3% | -109.5% |
5 y5 years | - | - |
TPST Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -130.3% | at low | -109.5% | at low |
5 y | 5 years | -130.3% | at low | -169.4% | at low |
alltime | all time | -130.3% | at low | -169.4% | at low |
Tempest Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$193.29 M(+5.8%) |
June 2024 | - | -$182.74 M(+5.5%) |
Mar 2024 | - | -$173.17 M(+4.8%) |
Dec 2023 | -$165.26 M(+21.7%) | -$165.26 M(+4.7%) |
Sept 2023 | - | -$157.78 M(+4.5%) |
June 2023 | - | -$150.99 M(+5.3%) |
Mar 2023 | - | -$143.41 M(+5.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | -$135.77 M(+35.7%) | -$135.77 M(+7.2%) |
Sept 2022 | - | -$126.67 M(+7.6%) |
June 2022 | - | -$117.72 M(+8.4%) |
Mar 2022 | - | -$108.55 M(+8.5%) |
Dec 2021 | -$100.06 M(+39.4%) | -$100.06 M(+8.4%) |
Sept 2021 | - | -$92.28 M(+9.6%) |
June 2021 | - | -$84.17 M(+17.3%) |
Dec 2020 | -$71.76 M | -$71.76 M |
FAQ
- What is Tempest Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Tempest Therapeutics?
- What is Tempest Therapeutics annual retained earnings year-on-year change?
- What is Tempest Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly retained earnings year-on-year change?
What is Tempest Therapeutics annual retained earnings?
The current annual retained earnings of TPST is -$165.26 M
What is the all time high annual retained earnings for Tempest Therapeutics?
Tempest Therapeutics all-time high annual retained earnings is -$71.76 M
What is Tempest Therapeutics annual retained earnings year-on-year change?
Over the past year, TPST annual retained earnings has changed by -$29.49 M (-21.72%)
What is Tempest Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TPST is -$193.29 M
What is the all time high quarterly retained earnings for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly retained earnings is -$71.76 M
What is Tempest Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TPST quarterly retained earnings has changed by -$35.52 M (-22.51%)